BioSpace News Archive

Drug Development

MAP Pharmaceuticals, Inc. Announces Completion of Enrollment in Phase 3 Trial of Unit Dose Budesonide in Children with Asthma

September 22, 2008
·
3 min read
Business

Ceragenix Pharmaceuticals, Inc. Satisfies Conditions for $1 Million Milestone Payment under Supply and Distribution Agreement

September 22, 2008
·
1 min read
Drug Development

European Medicines Evaluation Agency Grants Kiadis Pharma Lead Product ATIR(TM) Orphan Drug Designation

September 22, 2008
·
1 min read
Drug Development

Transdel Pharmaceuticals, Inc. Enrolls First Patient for Ketotransdel(TM) Phase 3 Clinical Trial

September 22, 2008
·
5 min read
Smith & Nephew plc - Transaction in Own Shares

September 22, 2008
·
1 min read
Drug Development

Baxter International, Inc. Initiates Phase III Trial for the Treatment of Alzheimer’s Disease

September 22, 2008
·
6 min read
Genetown

Boston Scientific Corporation to Participate in UBS Global Life Sciences Conference

September 22, 2008
·
1 min read
Genetown

Charles River Laboratories (Massachusetts) To Present At UBS Global Life Sciences Conference

September 22, 2008
·
1 min read
Drug Development

Isis Pharmaceuticals, Inc., Antisense Therapeutics Limited ATL/TV1102 Trial Results Presented at World Congress on Treatment and Research in Multiple Sclerosis

September 22, 2008
·
10 min read
Pharm Country

UBS Global Life Sciences Conference Opens In New York

September 22, 2008
·
1 min read